Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN113845488A reveals a robust synthesis for Parecoxib Sodium. Discover cost-effective sulfonation and refining methods for reliable pharmaceutical intermediates supply.
Novel solid-phase synthesis method for Pasireotide improves purity and yield. Reliable supplier offering cost reduction in pharmaceutical intermediates manufacturing.
Patent CN111471020B reveals a novel Rh-catalyzed route for Avapritinib intermediates, offering safer conditions and reduced costs for reliable API manufacturing.
Patent CN101638424A details novel astilbin derivatives enhancing solubility. Discover cost-effective synthesis routes for high-purity pharmaceutical intermediates.
Patent CN106146648A reveals high purity Abaloparatide synthesis. Fragment condensation ensures supply chain reliability and cost reduction for pharmaceutical intermediates manufacturing.
Patent CN103936767B details high-yield synthesis for Ticagrelor intermediates. Offers scalable, cost-effective manufacturing solutions for global pharmaceutical supply chains.
Novel patent CN111892635A offers cost-effective NR synthesis. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates.
Novel triazine-mediated route for high-purity Glycopyrronium Bromide. Reduces toxicity and improves yield for pharmaceutical manufacturing.
Patent CN115057794B enables visible light-induced demethylation. Offers cost reduction and supply chain reliability for high-purity pharmaceutical intermediates manufacturing.
Patent CN108715881B reveals a dual-enzyme route for pregabalin intermediates. Achieve 99.5% e.e. and simplified processing for cost-effective API manufacturing.
Novel NHC catalyzed visible light synthesis method offers green efficient production for pharmaceutical intermediates supply chain.
Novel patent CN108467388A details improved Afatinib synthesis avoiding cis-trans isomers, ensuring high purity and supply chain stability for pharmaceutical manufacturing.
Patent CN110229796B details enzymatic synthesis for high-purity duloxetine intermediates. Offers cost reduction and supply chain reliability for pharma manufacturing.
Novel catalytic hydrogenation route for 2-Amino-4-nitrophenol. Reduces pollution and enhances supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN107602652A enables high-purity reference substance production for methylprednisolone impurity control and supply chain stability.
Advanced refining method for Lenvatinib Mesylate achieving >99.8% purity. Optimized crystallization reduces costs and ensures supply chain reliability for pharmaceutical manufacturers.
Patent CN110951799A reveals a novel whole-cell enzymatic route for high-purity (2S,3R)-p-methylsulfonylphenylserine, offering significant cost reduction and scalable green manufacturing for antibiotic intermediates.
Patent CN119776462A reveals one-pot enzymatic synthesis for pseudouridine. High purity and yield offer significant supply chain and cost advantages for mRNA manufacturers.
Patent CN110804038B reveals a safer zinc-catalyzed route for tedizolid phosphate intermediates, offering high purity and industrial scalability for API manufacturing.
Patent CN103936809B reveals improved synthesis for dexamethasone phosphate intermediate ensuring higher purity and yield for reliable pharmaceutical intermediate supply chains.